• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

研究蛋白质二级结构对基于β-乳球蛋白无定形固体分散体溶解行为的影响。

Investigating the influence of protein secondary structure on the dissolution behavior of β-lactoglobulin-based amorphous solid dispersions.

机构信息

Department of Pharmacy, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark.

Zerion Pharma A/S, Blokken 11, DK-3460 Birkerød, Denmark.

出版信息

Int J Pharm. 2024 Mar 25;653:123887. doi: 10.1016/j.ijpharm.2024.123887. Epub 2024 Feb 10.

DOI:10.1016/j.ijpharm.2024.123887
PMID:38346599
Abstract

Proteins acting as carriers in amorphous solid dispersions (ASDs) demonstrate a notable sensitivity to the spray drying process, potentially leading to changes in their conformation. The main aim of this study was to investigate the dissolution performance of ASDs based on proteins with different content of secondary structures, specifically β-sheet and α-helix structures. We prepared β-sheet-rich and α-helix-rich β-lactoglobulin (BLG), along with corresponding ASDs containing 10 wt% and 30 wt% drug loadings, through spray drying using celecoxib as the model drug. Circular dichroism and Fourier Transform Infrared Spectroscopy results revealed that even though changes in secondary structure were obtained in the spray-dried powders, the BLGs exhibited reversibility upon re-dissolving in phosphate buffer with varying pH levels. Both β-sheet-rich BLG and α-helix-rich BLG exhibited enhanced dissolution rates and higher solubility in the media with pH values far from the isoelectric point (pI) of BLG (pH 2, 7, 8, and 9) compared to the pH closer to the pI (pH 3, 4, 5, and 6). Notably, the release rate and solubility of the drug and BLG from both types of BLG-based ASDs at 10 wt% drug loading were largely dependent on the solubility of pure SD-BLGs. α-helix-rich BLG-ASDs consistently exhibited equivalent or superior performance to β-sheet-rich BLG-ASDs in terms of drug release rate and solubility, regardless of drug loading. Moreover, both types of BLG-based ASDs at 10 wt% drug loading exhibited faster release rates and higher solubility, for both the drug and BLG, compared to the ASDs at 30 wt% drug loading in pHs 2, 7, and 9 media.

摘要

在无定形固体分散体(ASD)中作为载体的蛋白质对喷雾干燥过程表现出显著的敏感性,可能导致其构象发生变化。本研究的主要目的是研究具有不同二级结构(β-折叠和α-螺旋结构)含量的蛋白质 ASD 的溶解性能。我们通过喷雾干燥制备了富含β-折叠和富含α-螺旋的β-乳球蛋白(BLG),并使用塞来昔布作为模型药物制备了相应的含有 10wt%和 30wt%药物负载的 ASD。圆二色性和傅里叶变换红外光谱结果表明,尽管喷雾干燥粉末中存在二级结构的变化,但 BLG 在不同 pH 值的磷酸盐缓冲液中重新溶解时表现出可逆性。与接近 BLG 等电点(pI)的 pH 值(pH 3、4、5 和 6)相比,富含β-折叠的 BLG 和富含α-螺旋的 BLG 都表现出更高的溶解速率和更高的在远离 BLG pI(pH 2、7、8 和 9)的介质中的溶解度。值得注意的是,在 10wt%药物负载下,两种类型的基于 BLG 的 ASD 中的药物和 BLG 的释放速率和溶解度在很大程度上取决于纯 SD-BLG 的溶解度。在药物释放速率和溶解度方面,富含α-螺旋的 BLG-ASD 始终表现出与富含β-折叠的 BLG-ASD 相当或更优的性能,而与药物负载无关。此外,在 pH 2、7 和 9 介质中,与 30wt%药物负载的 ASD 相比,两种类型的 BLG 基 ASD 都表现出更快的药物和 BLG 释放速率和更高的溶解度。

相似文献

1
Investigating the influence of protein secondary structure on the dissolution behavior of β-lactoglobulin-based amorphous solid dispersions.研究蛋白质二级结构对基于β-乳球蛋白无定形固体分散体溶解行为的影响。
Int J Pharm. 2024 Mar 25;653:123887. doi: 10.1016/j.ijpharm.2024.123887. Epub 2024 Feb 10.
2
Exploring the effect of protein secondary structure on the solid state and physical stability of protein-based amorphous solid dispersions.探讨蛋白质二级结构对蛋白质无定形固体分散体的固体状态和物理稳定性的影响。
Eur J Pharm Biopharm. 2024 May;198:114274. doi: 10.1016/j.ejpb.2024.114274. Epub 2024 Mar 30.
3
Mechanisms of Drug Solubility Enhancement Induced by β-Lactoglobulin-Based Amorphous Solid Dispersions.β-乳球蛋白基无定形固体分散体提高药物溶解度的机制。
Mol Pharm. 2023 Oct 2;20(10):5206-5213. doi: 10.1021/acs.molpharmaceut.3c00577. Epub 2023 Sep 5.
4
β-Lactoglobulin-based amorphous solid dispersions: A graphical review on the state-of-the-art.基于β-乳球蛋白的无定形固体分散体:最新技术的图文综述。
Eur J Pharm Biopharm. 2024 Sep;202:114396. doi: 10.1016/j.ejpb.2024.114396. Epub 2024 Jul 4.
5
Enhanced dissolution rate of nimodipine through β-lactoglobulin based formulation.通过基于β-乳球蛋白的制剂提高尼莫地平的溶出速率。
Int J Pharm. 2023 Mar 25;635:122693. doi: 10.1016/j.ijpharm.2023.122693. Epub 2023 Feb 7.
6
Insights into the Dissolution Mechanism of Ritonavir-Copovidone Amorphous Solid Dispersions: Importance of Congruent Release for Enhanced Performance.利托那韦-共聚维酮无定形固体分散体的溶解机制研究:一致释放对于增强性能的重要性。
Mol Pharm. 2019 Mar 4;16(3):1327-1339. doi: 10.1021/acs.molpharmaceut.8b01261. Epub 2019 Feb 5.
7
Protein Based Amorphous Solid Dispersion: a Case Study Investigating Different Whey Proteins at High Drug Loading.基于蛋白质的无定形固体分散体:一项考察高载药量下不同乳清蛋白的案例研究。
Pharm Res. 2023 Jul;40(7):1865-1872. doi: 10.1007/s11095-023-03542-9. Epub 2023 May 26.
8
Inhomogeneous Phase Significantly Reduces Oral Bioavailability of Felodipine/PVPVA Amorphous Solid Dispersion.非均相显著降低非洛地平/PVPVA无定形固体分散体的口服生物利用度。
Mol Pharm. 2023 Jan 2;20(1):409-418. doi: 10.1021/acs.molpharmaceut.2c00695. Epub 2022 Dec 18.
9
Congruent Release of Drug and Polymer from Amorphous Solid Dispersions: Insights into the Role of Drug-Polymer Hydrogen Bonding, Surface Crystallization, and Glass Transition.无定形固体分散体中药物和聚合物的一致释放:对药物-聚合物氢键、表面结晶和玻璃化转变作用的深入了解。
Mol Pharm. 2020 Apr 6;17(4):1261-1275. doi: 10.1021/acs.molpharmaceut.9b01272. Epub 2020 Mar 17.
10
A Comparative Study between A Protein Based Amorphous Formulation and Other Dissolution Rate Enhancing Approaches: A Case Study with Rifaximin.基于蛋白质的无定形制剂与其他溶出速率提高方法的比较研究:以利福昔明为例
Pharmaceutics. 2022 Dec 30;15(1):126. doi: 10.3390/pharmaceutics15010126.

引用本文的文献

1
Curcumin Solubility and Bioactivity Enhancement Through Amorphization with Tryptophan via Supercritical Fluid Technology.通过超临界流体技术与色氨酸非晶化提高姜黄素的溶解度和生物活性
Int J Mol Sci. 2025 Jan 20;26(2):855. doi: 10.3390/ijms26020855.
2
Surface Solid Dispersion of Ketoconazole on Trehalose Dihydrate using Spray Drying to Achieve Enhanced Dissolution Rate.喷雾干燥表面固体分散酮康唑二水合物以提高溶解速率。
AAPS PharmSciTech. 2024 Sep 23;25(7):220. doi: 10.1208/s12249-024-02941-4.